Catalyst Wire Dossier Catalyst Wire Dossier

NAYZILAM

midazolam · UCB, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NAYZILAM, covering 2019-05-17 to 2023-01-13. Get the full timeline:

Most recent: FDA Approved: NAYZILAM — Supplemental Application (UCB, Inc.)

See pricing